Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - ASEAN

ASEAN

The Diabetes Care Devices market market in the Association of Southeast Asian Nations (in Association of Southeast Asian Nations (ASEAN)) is expected to witness significant growth in the coming years.
By 2024, the projected revenue for this market is estimated to reach US$0.58bn.
This indicates a promising outlook for the region's diabetes care industry.
Furthermore, the market is anticipated to exhibit a compound annual growth rate (CAGR) of 13.86% between 2024 and 2029.
This steady growth trajectory is projected to lead to a market volume of approximately US$1.11bn by 2029.
These figures highlight the potential for expansion within the Diabetes Care Devices market market in in Association of Southeast Asian Nations (ASEAN).
In terms of global comparison, it is worth noting that the United States is expected to generate the highest revenue in the Diabetes Care Devices market market.
In 2024 alone, the projected revenue for the United States is estimated to reach a substantial US$11,710.00m.
This demonstrates the significance of the US market in the global diabetes care industry.
In the ASEAN region, Singapore leads the way in the Diabetes Care Devices market with its advanced healthcare infrastructure and high disposable income.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.